UnitedHealth shares fall about 19% intraday after weak 2026 revenue outlook

UnitedHealth stock dropped sharply on the day it issued its 2026 outlook, down about 19% in midday trading. Revenue guidance came in well below the roughly $454 billion analysts had expected, while adjusted EPS guidance roughly matched forecasts.

• Down about 19% in midday trading on January 27, 2026
• Revenue guidance above $439 billion vs about $454.2 billion expected
• Adjusted EPS guidance above $17.75 vs about $17.74 expected
• Planned Medicare Advantage membership reduction of about 1.4 million